Results per Page:

Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division

Dense tumor extracellular matrix impedes immunotherapy infiltration
From the Warren and Tykodi Labs, Translational Science and Therapeutics Division

Extending efficacy for CAR T-cell therapies
Dr. Shivani Srivastava receives NCI MERIT Award to investigate how to improve engineered cancer immunotherapies against solid tumors through reservoirs of self-renewing immune cells

H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer

Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors

Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award
Celebrating faculty and staff achievements

Beyond Ben Stiller’s advice: What the experts say about PSA screening
The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened

‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next

GI oncologist Coveler joins Center
Andrew Coveler adds cancer immunotherapy, translational research expertise to Clinical Research Division

Study of Japanese atomic bomb survivors shows radiation exposure poses similar risk of first and second cancers
First large-scale study to assess how radiation influences risk of multiple cancers

Fred Hutchinson Cancer Research Center receives a pledge of $10 million to bolster immunotherapy research
Gift fosters research that harnesses the immune system to fight cancer

Patient's cloned T cells kill tumors
Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission

Science Backgrounder: Nothing Small About "Mini-Transplants"
Developed at the Hutchinson Center, therapy uses minimal doses of radiation